Novavax (NVAX) Net Margin Growth (5y) (2015 - 2026)
Novavax (NVAX) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Novavax |
1.49 Bn |
931.98 Mn |
108.82 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
4,300.00 |
| Dec 31, 2025 |
7,540.00 |
| Sep 30, 2025 |
-16,163.00 |
| Jun 30, 2025 |
11,016.00 |
| Mar 31, 2025 |
84,369.00 |
| Dec 31, 2024 |
26,932.00 |
| Sep 30, 2024 |
57,637.00 |
| Jun 30, 2024 |
121,856.00 |
| Mar 31, 2024 |
92,782.00 |
| Dec 31, 2023 |
74,391.00 |
| Sep 30, 2023 |
50,603.00 |
| Jun 30, 2023 |
42,756.00 |
| Mar 31, 2023 |
11,746.00 |
| Dec 31, 2022 |
43,776.00 |
| Sep 30, 2022 |
51,125.00 |
| Jun 30, 2022 |
38,592.00 |
| Mar 31, 2022 |
80,117.00 |
| Sep 30, 2021 |
187,063.00 |
| Jun 30, 2021 |
304,905.00 |
| Mar 31, 2021 |
178,090.00 |
